The OneRNA® Platform
One assay. All mRNAs. Every disease.
RNA
RNA is destroyed in a real clinical sample. OneRNA enables RNA-seq in such samples
Normal
Patients' samples are compared to a database of true normal to statistically power the information
Drugs
A curated, drug–target–ligand database connects very abnormal genes to treatments
How it works
How do we compare
DNA sequencing has demonstrated its clinical value, but missing a very important layer of information. Both types of testing are necessary to uncover all options for a patient and can be billed under separate payor codes
DNA Panels
500-geneTypical 500 genes -> binary test
OneRNA
20,000 RNA's -> quantitatively
40% of patients matched to one drug
Drops to 26% in low mutation tumors
Almost 100% of patients matched to a drug
Matching to typically more than one option
Does not detect
- Over-Expression
- Fusions
- Immune therapy targets
- Tumor Microenvironment
Detects
- Over-expression
- Fusions
- Immune therapy targets
- Tumor Microenvironment
Contact us
We'll get in touch with you soon
Subscribe to our newsletter
100 Cummings Center, Suite 451C, Beverly, MA 11954
Terms & Conditions
Privacy Policy